U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IMMUNOTHERAPEUTIC VACCINE CONSISTING OF (PAM)2-LYS-SER-SER-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-ALA-ALA-ALA-PHE-LEU-PRO-SER-ASP-PHE-PHE-PRO-SER-VAL
Preferred Name English
CY-1899
Code English
L-Valine, N2,N6-bis(1-oxohexadecyl)-L-lysyl-L-seryl-L-seryl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-?-glutamyl-L-alanyl-L-alanyl-L-alanyl-L-phenylalanyl-L
Systematic Name English
CY 1899 [WHO-DD]
Common Name English
THERADIGM HBV
Common Name English
CY1899
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 74893
Created by admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
Code System Code Type Description
CAS
186511-30-8
Created by admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
PRIMARY
FDA UNII
HM7AT2E2B6
Created by admin on Mon Mar 31 21:27:04 GMT 2025 , Edited by admin on Mon Mar 31 21:27:04 GMT 2025
PRIMARY
ACTIVE MOIETY
CY-1899
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966